FindTrial
Sign In

Biological tests for major depressive disorder that involve leukocyte gene expression assays.

Biological tests for major depressive disorder that involve leukocyte gene expression assays. - Biological tests for major depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016097
Enrollment
120
Registered
2015-01-01
Start date
2005-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Biological tests for major depressive disorder that involve leukocyte gene expression assays.

Sponsors

Course of Integrated Brain Sciences, University of Tokushima School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with major depressive disorder.

Exclusion criteria

Exclusion criteria: Exclusion criteria for MDDs have not used non-steroidal anti-inflammatory agents, steroids, antipsychotic medications, and anticonvulsants at least past 2 months.

Design outcomes

Primary

MeasureTime frame
sensitivity and specificity—

Countries

Japan

Contacts

Public ContactJunichi Iga

Course of Integrated Brain Sciences, University of Tokushima School of Medicine Department of Psychiatry

igajunichi@hotmail.com+81-86-633-7130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026